GSM5025312: S2.1: Sensitive PH039 second passage source tumor (rrbs);... - SRA

SRX9892282: GSM5025312: S2.1: Sensitive PH039 second passage source tumor (rrbs); Homo sapiens; Bisulfite-Seq
1 ILLUMINA (Illumina MiSeq) run: 384,647 spots, 116.1M bases, 60.6Mb downloads

Submitted by: NCBI (GEO)

Study: Targeted (amplicon) reduced representation bisulfite sequencing (RRBS) data for HGSOC PH039 PDXs at baseline and treated with cycles of 100 mg/kg niraparib for 21 days for four treatment rounds

PRJNA693043 • SRP302257 • All experiments • All runs

show Abstracthide Abstract

Targeted (amplicon) reduced representation bisulfite sequencing (RRBS) data for HGSOC PH039 PDXs at baseline and treated with cycles of 100 mg/kg niraparib for 21 days for four treatment rounds. Overall design: RBBS data of 12 samples: Niraparib arm (n=8) with up to four cycles of treatment or source tumor arm (n=4) with 0-5 passages in absence of drug.

Sample: S2.1: Sensitive PH039 second passage source tumor (rrbs)

SAMN17376286 • SRS8071639 • All experiments • All runs

Organism: Homo sapiens

Library:

Instrument: Illumina MiSeq

Strategy: Bisulfite-Seq

Source: GENOMIC

Selection: Reduced Representation

Layout: PAIRED

Construction protocol: Nextera XT libraries were prepared from Nextera Index Kit v2 set B or set C barcoding primers were integrated into amplicons to create illumina sequecing libraries (Iluumina, cat #FC-131-2002 or FC-131-2003). RRBS sequenced on the Illumina MiSeq using Miseq Nano Reagent Kit v2 (Illumina; Cat# MS-102-2002).

Experiment attributes:

GEO Accession: GSM5025312

Links:

NCBI link: NCBI Entrez (gds)

Runs: 1 run, 384,647 spots, 116.1M bases, 60.6Mb

Run	# of Spots	# of Bases	Size	Published
SRR13479565	384,647	116.1M	60.6Mb	2021-06-17

ID:: 12945131

SRA

Sequence Read Archive

Result Filters

Send to:

Supplemental Content

Related information

Search details

Recent activity